Discovery of indazole aldosterone synthase (CYP11B2) inhibitors as potential treatments for hypertension.
Bioorg Med Chem Lett
; 27(11): 2384-2388, 2017 06 01.
Article
en En
| MEDLINE
| ID: mdl-28416132
ABSTRACT
We report the discovery and hit-to-lead optimization of a structurally novel indazole series of CYP11B2 inhibitors. Benchmark compound 34 from this series displays potent inhibition of CYP11B2, high selectivity versus related steroidal and hepatic CYP targets, and lead-like physical and pharmacokinetic properties. On the basis of these and other data, the indazole series was progressed to lead optimization for further refinement.
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Citocromo P-450 CYP11B2
/
Hipertensión
/
Indazoles
/
Antihipertensivos
Límite:
Animals
/
Humans
/
Male
Idioma:
En
Revista:
Bioorg Med Chem Lett
Asunto de la revista:
BIOQUIMICA
/
QUIMICA
Año:
2017
Tipo del documento:
Article